You are here » Home » Companies » Company Overview » Dr Agarwals Eye Hospital Ltd

Dr Agarwals Eye Hospital Ltd.

BSE: 526783 Sector: Health care
NSE: N.A. ISIN Code: INE934C01018
BSE 00:00 | 06 Oct 1094.55 44.50
(4.24%)
OPEN

1100.00

HIGH

1177.00

LOW

1085.00

NSE 05:30 | 01 Jan Dr Agarwals Eye Hospital Ltd
OPEN 1100.00
PREVIOUS CLOSE 1050.05
VOLUME 2008
52-Week high 1199.00
52-Week low 395.05
P/E 15.16
Mkt Cap.(Rs cr) 514
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1100.00
CLOSE 1050.05
VOLUME 2008
52-Week high 1199.00
52-Week low 395.05
P/E 15.16
Mkt Cap.(Rs cr) 514
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - Chairman Speech

Company chairman speech

Dear Shareholders

Hope you and your family are well and safe.

We started our journey 60 years ago with a challenge to build an organization thatwould offer high quality eye care at affordable prices. This continued effort over theyears has helped us earn the trust of millions of people across the world while stayingtrue to our vision of being a truly global healthcare organization which imbibes the bestpractices from different sectors while relying on continuous innovation and cutting-edgetechnology.

Our Centers continue to differentiate themselves through clinical excellence highstandards of quality and skilled experienced doctors. Dr Agarwal's has risen to thechallenge of delivering quality eye care during this COVID era as well. I would at thistime like to acknowledge the efforts of our doctors and support staff who have shownfierce determination and dedication in performing their duties. This gives me theconfidence that we can overcome any challenge that may come our way and enable us to servethe interests of all our stakeholders.

For FY 2020-21 we clocked INR 139.81 Crores as revenue from operations with ProfitBefore tax at 5.73 Crores. Our performance was greatly affected in the first half of theyear due to the impact of COVID-19 crisis and things started returning to normal in thelatter half of the year. We relocated our Salem branch (in Quarter 3) to a bigger premiseto address the market demands and the center showed significant traction afterre-location. During the Financial Year 2021-22 we focus on building additional capacitywith an aim to create a world class facility at Chennai. While affirming our faith thatinnovation and technology will be at the forefront of our growth we will also beinvesting more on bio-medical equipments and Infrastructure this year. We have alsostrengthened our compliance process and will continue to do so.

As we move ahead on the path of value creation for all our stakeholders I would liketo commend the effort of our management and staff. I thank all the Directors for theirvalued insights and directions imparted to the Company. The trust and confidence of theShareholders fuel us on the path of excellence and I look forward to this continuedsupport.

Regards
Dr Amar Agarwal
Chairman and Managing Director
Dr Agarwal's Eye Hospitals Limited

.